Cite

HARVARD Citation

    Bernardi, M. et al. (n.d.). Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs. American journal of hematology. 91 (6), pp. E302-E303. [Online]. 
  
Back to record